About us Contacts Interactions: 118 620
Drug search by name

HyperRHO S/D and Anemia

Result of checking the interaction of drug HyperRHO S/D and disease Anemia for safety when used together.

Check result:
HyperRHO S/D <> Anemia
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of RHo (D) immune globulin is contraindicated in patients with autoimmune hemolytic anemia, with preexisting hemolysis or at high risk for hemolysis. Patients that have lower than normal hemoglobin levels (less than 10 g/dL), a reduced dose of 125 to 200 international unit/kg (25 to 40 mcg/kg) should be given to minimize the risk of increasing the severity of anemia. Alternative treatments should be used in patients with hemoglobin levels that are less than 8 g/dL due to the risk of increasing the severity of the anemia. Patients should be monitored to determine clinical response by assessing platelet counts, RBCs, hemoglobin, and reticulocyte levels.

HyperRHO S/D

Generic Name: rho (d) immune globulin

Brand Name: HyperRHO S/D Full Dose, HyperRHO S/D Mini Dose, MicRhoGAM, MicRhoGAM Ultra-Filtered Plus, RhoGAM, RhoGAM Ultra-Filtered Plus, Rhophylac, WinRho SDF, Gamulin Rh, Mini-Gamulin Rh, HypRho-D Mini-Dose, BayRho-D, BayRHo-D Full Dose, BayRHo-D Mini-Dose, Anti-D Immunoglobulin, D-Gam Anti-D, Partobulin SDF, Liberim D

Synonyms: HyperRHO S/D Full Dose

Interaction with food and lifestyle
Drug interactions